Jay Mohr And Martin Stogniew Join Zelos Therapeutics To Develop Exciting New Osteoporosis Drug, Ostabolin-C(TM)

WEST CONSHOHOCKEN, Pa. & OTTAWA--(BUSINESS WIRE)--May 18, 2006--Zelos Therapeutics, Inc. today announced two executive appointments that will strengthen the Company’s management team as the Company progresses to a new stage in its development. Joseph S. “Jay” Mohr joins the company as Chief Business Officer and Martin Stogniew, Ph.D. joins the company as Executive Vice President of Development.

MORE ON THIS TOPIC